Breaking News Instant updates and real-time market news.

ABT

Abbott

$55.06

0.43 (0.79%)

, USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

20:25
10/17/17
10/17
20:25
10/17/17
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Abbott (ABT), consensus 65c... U.S. Bancorp (USB), consensus 88c... SUPERVALU (SVU), consensus 35c.

ABT

Abbott

$55.06

0.43 (0.79%)

USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

SVU

Supervalu

$19.38

0.57 (3.03%)

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 17

    Jan

ABT Abbott
$55.06

0.43 (0.79%)

10/02/17
BMOC
10/02/17
NO CHANGE
BMOC
Dexcom expected to remain significant player in diabetes, says BMO Capital
After BMO Capital conducted a survey of 27 doctors, Joanne Wuensch, an analyst at the firm, says the data indicates that "DexCom's (DXCM) CGM devices should have their place in the diabetes treatment paradigm" following the FDA's approval of Abbott's (ABT) competing Libre product. Specifically, the survey shows that overall CGM prescriptions will increase, while DexCom will maintain a 34% share of type 1 CGM allocations and a 25% share of type 2 allocations, according to Wuensch, The analyst expects DexCom's revenue to rise 23% next year and 18% in 2019. She keeps an Outperform rating on the stock.
10/06/17
JPMS
10/06/17
INITIATION
Target $60
JPMS
Neutral
Abbott reinstated with a Neutral at JPMorgan
JPMorgan analyst Michael Weinstein reinstated Abbott Laboratories with a Neutral rating and $60 price target. The analyst views the company as a 5.0% organic sales grower with the ability to deliver low double-digit earnings growth in 2018-2019 on acquisition synergies and deleveraging.
10/06/17
10/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GoDaddy (GDDY) initiated with an Outperform at William Blair. 2. Green Dot (GDOT) initiated with a Buy at Craig-Hallum. 3. Abbott (ABT) reinstated with a Neutral at JPMorgan. 4. Caesars (CZR) initiated with a Neutral at Nomura Instinet. 5. Tech Data (TECD) initiated with a Buy at Pivotal Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
10/09/17
NO CHANGE

Valuations in Medical Technology look more attractive, says RBC Capital
RBC Capital analyst Glenn Novarro says the recent pullback in Medical Technology stocks since Q2 earnings has eliminated the valuation gap relative to other S&P Health Care subsectors. The analyst recommends a "Buy Now" for Johnson & Johnson (JNJ) and "Buy on Weakness" for Abbott Laboratories (ABT) among diversified MedTech names. In Cardiovascular, Novarro says "Buy Now" for Edwards Lifesciences (EW) and "Buy on Weakness" for Boston Scientific (BSX). For Nuvasive (NUVA) and Wright Medical (WMGI), the analyst says management will cut guidance because of hurricane related revenue shortfalls, but the selloff over the past several weeks is already discounting those expectations.
USB U.S. Bancorp
$53.88

-0.38 (-0.70%)

08/09/17
WELS
08/09/17
INITIATION
Target $56
WELS
Market Perform
U.S. Bancorp resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of U.S. Bancorp with a Market Perform rating and $56 price target.
10/02/17
BOFA
10/02/17
DOWNGRADE
Target $54
BOFA
Underperform
U.S. Bancorp downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Erika Najarian downgraded U.S. Bancorp to Underperform and lowered its price target to $54 from $56 saying shares could "lag" peers. The analyst believes the banking sector is reaching an "inflection point in terms of the micro environment and expects U.S. Bancorp to deliver slower improvement in returns and capital distribution versus peers. Additionally, Najarian thinks ongoing pressure on both revenue and expenses could lead earnings risk and expects underperforamnce to continue.
09/28/17
NOMU
09/28/17
DOWNGRADE
NOMU
Neutral
U.S. Bancorp downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Bill Carcache downgraded U.S. Bancorp (USB) to Neutral saying he sees downside risk to net interest income and provision expectations. Consensus expects U.S. Bancorp's loan growth to accelerate to 6% by 2018, which is too optimistic given the bank's recent comments, the analyst contends. He lowered his price target for the shares to $55 from $57. Carcache remains bullish on Wells Fargo (WFC) and raised his price target for the shares to $65 from $64.
07/20/17
ARGS
07/20/17
UPGRADE
ARGS
Buy
U.S. Bancorp upgraded on results at Argus
As noted earlier, Argus upgraded U.S. Bancorp to Buy from Hold. Analyst Stephen Biggar upgraded the stock after the company reported its Q2 results. As reasons for the upgrade, he cited its "above-peer-average return on equity, return on assets and efficiency metrics, as well as earnings consistency," Target $57.
SVU Supervalu
$19.38

0.57 (3.03%)

06/26/17
PIVT
06/26/17
DOWNGRADE
Target $20
PIVT
Sell
SpartanNash downgraded to Sell from Hold at Pivotal Research
Pivotal Research analyst Ajay Jain downgraded SpartanNash (SPTN) to Sell and cut his price target for the shares to $20 from $35. Setbacks at the company's Military Distribution Segment suggest revenue trends for the military commissary business are unlikely to stabilize soon, Jain tells investors in a research note. He believes the stock's valuation premium to Kroger (KR) and Supervalu (SVU) is not warranted.
06/28/17
RBCM
06/28/17
NO CHANGE
RBCM
Supervalu shares 'very attractive' after retreat, says RBC Capital
RBC Capital analyst William Kirk says that the synergies from Supervalu's acquisition of Unified Grocers can exceed its guidance, while Supervalu's wholesale revenue looks set to meaningfully exceed expectations in fiscal 2018. The analyst says that the decline in the stock following the Whole Foods deal is overdone, as Supervalu obtains the lion's share of its revenue from its wholesale business and has a much less urban customer base than Whole Foods Kirk says that Supervalu's stock is "Very attractive" at current levels and keeps a $6 price target and an Outperform rating on the shares.
08/25/17
08/25/17
NO CHANGE

Price cuts not a 'silver bullet' for Amazon to disrupt grocery, says Citi
Citi analyst Alvin Concepcion noted that a number of food retail stocks sold off yesterday after Amazon (AMZN) announced price reductions on certain top selling items at Whole Foods (WFM) stores beginning on Monday when their deal closes, but he contends "price cuts alone are not a silver bullet to becoming a disruptive threat" in an industry that already has many discount operators. He adds that he would be wary of a more significant negative overreaction to news around Amazon's price plans at Whole Foods at this time. Some of the food retailing stocks that declined yesterday included Wal-Mart (WMT), Target (TGT), Kroger (KR), Sprouts Farmers Market (SFM), Costco (COST) and Supervalu (SVU).
06/19/17
RBCM
06/19/17
NO CHANGE
RBCM
Food retailers, distributors weakness overdone, says RBC Capital
RBC Capital analyst Bill Kirk says that the weakness in food retailers and distributors in reaction to Amazon's (AMZN) acquisition of Whole Foods (WFM) was overdone. The analyst says he doesn't expect Amazon to "drastically change" the prices in Whole Foods' physical stores. Instead, he expects it to exploit the company's brand through Prime and its "high-population density real estate." Other food retailers include Sprouts Farmers Market (SFM) and Kroger (KR), while Smart & Final Stores (SFS) and Supervalu (SVU) are food distributors.

TODAY'S FREE FLY STORIES

DKS

Dick's Sporting

$28.40

-0.7 (-2.41%)

14:30
11/21/17
11/21
14:30
11/21/17
14:30
Options
Dicks Sporting Goods draws put writing »

Dicks Sporting Goods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

GE

General Electric

$17.88

-0.105 (-0.58%)

14:20
11/21/17
11/21
14:20
11/21/17
14:20
Options
Repeat action in GE »

Repeat action in GE. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
11/21/17
11/21
14:17
11/21/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
11/21/17
11/21
14:16
11/21/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

, PFE

Pfizer

$35.61

0.2648 (0.75%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Hot Stocks
FDA approves ViiV Healthcare's two drug HIV treatment Juluca »

The FDA today said it…

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

PFE

Pfizer

$35.61

0.2648 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 07

    Dec

  • 14

    Dec

OCLR

Oclaro

$6.49

-0.09 (-1.37%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Options
Oclaro call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

NUE

Nucor

$56.02

0.46 (0.83%)

14:04
11/21/17
11/21
14:04
11/21/17
14:04
Hot Stocks
Nucor announces plans to build rebar micro mill »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

14:01
11/21/17
11/21
14:01
11/21/17
14:01
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:59
11/21/17
11/21
13:59
11/21/17
13:59
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SSNLF

Samsung

, WHR

Whirlpool

$166.91

1.71 (1.04%)

13:58
11/21/17
11/21
13:58
11/21/17
13:58
Periodicals
ITC calls for tariff-rate quota on imported Samsung, LG washers, Reuters says »

The U.S. International…

SSNLF

Samsung

WHR

Whirlpool

$166.91

1.71 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RF

Regions Financial

$15.70

-0.16 (-1.01%)

13:55
11/21/17
11/21
13:55
11/21/17
13:55
Options
Regions Financial put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLMT

Calumet Specialty Products

$8.30

0.1 (1.22%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Hot Stocks
Calumet Specialty Products announces divestiture of Anchor Drilling Fluids »

Calumet Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$3.16

0.25 (8.59%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Conference/Events
ITUS to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.03

-0.0315 (-0.21%)

13:49
11/21/17
11/21
13:49
11/21/17
13:49
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

13:47
11/21/17
11/21
13:47
11/21/17
13:47
Hot Stocks
Stanley Furniture to sell substantially all its assets »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
11/21/17
11/21
13:40
11/21/17
13:40
General news
NY Fed's overnight reverse repo totaled $42.9 B (19 counterparties) »

NY Fed's overnight…

EYE

National Vision

$30.19

0.21 (0.70%)

13:33
11/21/17
11/21
13:33
11/21/17
13:33
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:32
11/21/17
11/21
13:32
11/21/17
13:32
Downgrade
Cytokinetics rating change  »

Cytokinetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LOW

Lowe's

$81.59

0.13 (0.16%)

13:27
11/21/17
11/21
13:27
11/21/17
13:27
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

WHR

Whirlpool

$165.67

0.47 (0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Periodicals
ITC suggests tariffs on washing machine imports above 1.2M units, Bloomberg says »

Two of four ITC officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$53.70

-0.15 (-0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Conference/Events
Armstrong World to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BMO

Bank of Montreal

$77.39

0.06 (0.08%)

13:21
11/21/17
11/21
13:21
11/21/17
13:21
Hot Stocks
BMO Financial Group enters partnership with CDL-Montreal »

BMO Financial Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.93

0.66 (0.75%)

13:20
11/21/17
11/21
13:20
11/21/17
13:20
Options
Buyer lays out 500K for three month upside in Procter and Gamble »

Buyer lays out 500K for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/21/17
11/21
13:20
11/21/17
13:20
General news
Fed Governor Powell's hearings for the position as Fed Chair »

Fed Governor…

$NSD

NASDAQ Market Internals

13:17
11/21/17
11/21
13:17
11/21/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.